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TIETE picture of the development oflung cancer in Norway has hitherto solely
been based upon the official mortality statistics, published yearly by
" Statistisk
Sentralbyr'a," a service of the Norwegian Government.
As very few individuals have been cured from lung cancer, the mortality
figures should give a fairly accurate account of the cases actually diagnosed and
registered.
Up to and including the year 1940, a Scandinavian classification of causes
of death was in use. The group
" lung cancer
" (no. 7027) included carcinomas
and other malignant tumours, except sarcomas, of the lung and pleura. In 1941
the intemational classification of 1938 was introduced. The group
" lung cancer
"
(no. 47b) was then to include only carcinomas of the lung and pleura. The omis-
sion of
" other mahgnant tumours
" made actuaRy very little difference on the
total number assigned to this group. The intemational classification of 1948
was introduced in 1951, and at present the group
" lung cancer
" includes the
numbers 162 and 163. The most important change is the exclusion of tumours
specified as secondary. This change in procedure has, however, not significantly
influenced the figures for lung cancer mortality.
The tendency then, has been towards an increasing limitation of the terni
lung cancer." But, even now it may be that certain tumours are differently
coded in different countries. Fspecially migbt be mentioned the lung adenonias,
benign and infiltrating, as well as some of the sahvary gland tumours of the
lungs. Histologically they are primary epithelial lung tumours. Clinically they
often represent a
" benign
" tumour, and systematically most students would
classify these tumours as benign. In a not unimportant number of cases they
nevertheless behave like
" lung cancer
" and accordingly are classified as such..
In the present Norwegian materials such tumours account for 10 to 15 per
cent of allpriniaryepitheliallung tumours.
Fig. I presents the absolute number of deatlis from lung cancer in Norway
from 1929 to 1952. In order to avoid the disturbance in comparability intro-
ducedby the 1948 classification, thefigures for 1951 and 1952 have beenadjusted,
according to the analysis of Dr. Julie E. Backer, Head of the Medical Statistics
Division of
" Statistisk Sentralby-rh," so that they very approximately represent
the figures that would have been found in group 47b, ifthe coding had takenplace
according to the 1938 classification. The figures are also given in Table 1.
If we consider the twenty years period, from 1930 to 1950, and we take as
the figures for the year 1930 the average ofthe years 1929-1931, we find for males
a numerical increase from 15 to 150 cases, and for females from II to 66 cases
This means a tenfold increase for males and a sixfold increase for females.210 L. KREYBERG
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FIG. l.-Lung cancer deaths in Norway, 1929-1952.
Inthe course ofthetwentyyears'periodthepopulationhas,however, increased
considerably and the size of each agge-group has chan ed.
Fig. 2 shows the lung cancer incidence adjusted to the age-distribution of
the 1930 popiilation. The pertinent figures are given in Table 1. This graph
repeats the tendency shown in the fig. 1, showing the gradual and paraRel rise'
lung cancer in both sexes up to the middle of the 1940's, however, with a shght
lead ofthe males. From thatperiod a marked change takes place. The number
of casesdiagnosed andregistered in males increases more than that ofthe females.
The corrections introduced in fig. 2 lead, h'owever, to a more accurate picture-
of the registered increase. In males this 'mcfease is from 0-11 per 10,000 living
in 1930 to 0-77 in 1950. The correspondina figures for females are 0-075 in 1930
and 0-34 in 1950. Again the. figures for 1930 a-re given as the mean value of the
years 1929-1931. Instead of a tenfold increase in males we find a sevenfold, and
instead of a sixfold increase in females, w-e find a four-and-a-half-fold.
In a recent paper Kreyberg (1954) has described 466 primary epithehal lung
tumours and typed the tumours in six main types, according to criteria previ-
ously stated (Kreyberg, 1952). The total material consisted of two post mortemLITNG CANCER IN NORWAY 211
TABLE I.-Lun Cancer Death8in Norway, 1929-1952.
Age-adjusted
mortality per 10,000
(Standard: 1930).
M. F.
0-0978 0-0574
0-0911 0-0769
0-1427 0-0912
0-1153 0-1030
0-1071 0-1704
0-1392 0-1201
0-2079 0-1326
0-1776 0-1900
0-2707 0-1874
0-1978 0-1911
0-2729 0-1886
0-2992 0-1673
0-3466 0-2819
0-3863 0-3007
0-3358 0-2227
0-2689 0-2727
0-3917 0-2412
0-3740 0-3225
0-4780 0-3442
0-5702 0-2390
0-6320 0-2778
0-7679 0-3387
0-6860 0-3270
Number of
deaths.
M. F.
13 8
12 11
20 13
16 15
15 25
20 18
30 20
26 29
40 29
35 30
41 30
46 27
55 46
63 51
56 38
45 47
67 44
66 58
88 64
106 45
119 54
150 66
133 65
161 82
Total population.
M. F.
1,361,219 1,433,536
1,368,169 1,439,269
1,377,417 1,446,482
1,387,435 1,454,131
1,397,041 1,461,332
1,406,123 1,468,110
1,414,729 1,474,512
1,422,952 1,480,590
1,431,644 1,487,118
1,441,191 1,494,633
1,451,412 1,503,030
1,461,361 1,511,728,
1,469,454 1,519,552
1,477,938 1,528,432
1,489,425 1,450,356
1,503,333 1,554,071
1,519,048 1,569,042
1,537,951 1,586,298
1,559,203 1,603,827
1,577,632 1,621,368
1,595,459 1,636,728
1,618,324 1,6459664
1,634,606 1,660,953
Year.
1929
1930
1931
193"
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
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FIG. 2.-Mortality from
" lung cancer
" per 10,000-Norway. Standard figures, 1929-51.
Two curves bave been drawn for females, the upper giving the figures standardized to the
female population in 1930, the lower thefigures standardized to the malepopulation.of 1930.212 L. KREYBERG
series (Christiansen (1953), 134 cases, and Jakobsen (1953), 100 cases), as well
as the authors own clinical material, embracing 232 cases.
The examination ofthehistologicaltypes, as well as the sex and age occurrence,
in the light of our present clinical and epidemiological kiiowledge lead to the
following conclusions : (i) Squamous cell, large-cefl and small-cell carcinomas
represent a biological entity. These tumotirs occur with a very marked prepon-
derance in males and they show an age-curve indicating that in the so-called
Western World potent carcinogenic factors of recent origin are ofaetiologic signi-
ficance. These tumours are designated Group I tumours. (ii) Adenocarcinomas
occur in Norway with the same frequeDCyin males and females, and this tumour
shows a steadily increasing occurrence with advancing years, indicating a stable
and moderate carcinogenic influence. (iii) Bronchiolar cell carcinomas are like-
wise evenly distributed among males and females, but there is no increase in the
higher age-groups. UDknown factors hitting at random are supposed responsible
for their development. (iv) Lung adenomas and salivary gland tumours of the
lungs sbow an equal sex distribution and occur in all ages. These facts, together
with thehistologicalpicture point in the direction ofdevelopmental factors being
responsible for their occurrence. These last four tumour types have been
,designated Group 11 tuniours.
If the three Norwegian materials are examined and Christiansen's (1953)
series is divided into two sub-series, according to two different time periods, we
get the figures as shown in Table II. A few cases, which occurred in both Cliris-
tiansen and Kreyberg's materials, have been included in the latter only in this
table.
TABLE II.
Group I tumours. Group 11 tumours.
Material. Males. Females. 'Kales. Females.
Christiansen (1953) covering the years
1925-1944 25 11 15 13
Christiansen (1953) covering the years
1945-1952/1 40 4 14 12
Jakobsen (1953) covering the vears
1937-1946 46 8 24 22
Kreyberg (I954) covering the years
1948-1953 162 8 28 29
Table 11 shows moststrikingly the uniform occurrence'oftheGroup II tumours
inthe two sexes in all the series, originating froni different time periods. It should
be emphasized that the present writer bas been responsible for all the histological
typing, and that the typing has been conducted at different periods and with
no knowledge of the files, nor the clinical bistories.
If the tentative conclusions presented above are correct, it would mean that
the Group 11 tumours should represent primarylung tumours unrelated to special
epidemiological circumstances, and that these tumours, with apossible reservation
regarding the adenocarcinomas, sbould have the same relative frequency to-day
as in the past. The adenocarcinomas mav have increased in frequency in recent
years, but the regular age-curve of this tumour type indicates that they have
not very recently been influenced bv external changes, in sharp contrast to theLUNG CANCER IN NORWAY 213
Group I tuniours. The consequence of this assumption should again be that an
increaseregistered forGroup II tumours would represent a measure of an increase
in diagnostic efficacy.
As regards the Group I tumours, Table II again clearly reveals interesting
facts. In the four time periods, tfie two middle partly overlapping, one may
observe that females, in accord with clinical experience, constantly present
a small number of Group I tumours. Compared now to the Group 11 tumours,
they are at least not increas'mg m frequency. No conclusion in the opposite
direction is drawn from the rather declining frequency because of the smafl
figures.
It may therefore be correct to regard the lung cancer in females to-dav as
an expression ofwhat Clemmesen, Nielsen and Jensen (1953) call
" unavoidable
lung cancer. This unavoidable lung cancer should include aR the Group II tu-
mours, as well as a smaR number ofGroup I tumours.
Ifthese assumptions are correct, the increase inlung cancer in females should
at least in Norwaytoday, be a fair index of the increased diagnostic efficacy. In
thetwentyyears' period 1930-1950 this increase isapproximately four-and-a-half-
fold. Wehave, however,probably notyet reachedthelimitation ofourdiagnostic
expansion. Although better diagnosis may in some cases lead to the discovery
of a primary site outside the lung, andthereby exercise a depressive effect on the
lung cancer mortahty registered, it seems more hkely that further improvements
at the present time willmainlyresult in an increase in the mortahtyfigures. We
ought, therefore, to accept even a furtlier increase in the lung cancermortahty
registered in females, without necessarily drawing the conclusion that more lung
cancer is actually developing. A very important clue as to a change in the
situation is the ratio ofthe different histological types in the material.
IfTable II andfig. 2 are correlated, one finds in males a differentdevelopment
taking place from the middle ofthe 1940's. From that period a marked increase
in Grou'p I tumours can be observed in males, at the same time as a pronounced
deviation in the mortality rates in the two sexes takes place. It seems that the
marked additional rise in lung tumours in males is caused solely by the Group I
tumours. The Group 11 tumours, on the other hand, closely follow the pattem
of the females. It may be that in the latest series (Kreyberg's) in Table II, the
difference between the Group I and II tumours is too marked to be whoRy repre-
sentative, because that material is a clinical one with an underrepresentation of
older people liable to develop adenocarcinomas. The tendency is clear, however,
and the development continues to-day.
At present it seems permissible to conclude that inNorway, during the twenty
years' period 1930-1950, the four-and-a-half-fold increase registered in lung
cancerin females is entirely caused by greater diagnostic efficacy. As the devel-
opment in males initiaRy closely followed that of the females, it seems reasonable
to accept the recent deviation in the mortality rates, as well as in the representa-
tion ofthehistologicaltypes, asindicating a newsituation, and toregardthe added
increase in lung cancer in males as an expression of a real increase. This should
mean the difference between a sevenfold and a four-and-a-half-fold increase.
The importance of this conclusion is not expressed by the magnitude of the
real riseto-day, but it is indicated by thetendency and the sliort time it has been
manifest. The increase in lung cancer in Norway has started later than in many other countries, but the pattern is identical.
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SUMMARY.
The figures from the official Norwegian mortality statistics have been analysed
on the background of the occurrence of different histological types of primary
epithelial lung tumours in two Norwegian post-mortem materials and a series of
clinical cases belonging to different time periods. It is found that in females the
ratio ofthe different tumour types has not changed appreciably, and the increase
in lung cancer in females is taken as indicator of the increased diagnostic efficacy.
In males, on the other hand, a relative increase in the number of squamous cell,
large-cell and small-cell carcinomas has taken place very recently, at the same
time as a pronounced deviation in the mortality rates between the two sexes has
developed. Accepting a four-and-a-half-fold increase in lung cancer in females
as caused by better diagnosis, the difference between this figure and the sevenfold
increase registered in males is taken to represent the real increase in the develop-
nient of lung cancer in males.
The histological sub-division of the primary epithelial lung tumours into
different histological and biological entities seems to be very useful in an analysis
ofthe actual development ofsuch tumours.
The present and the preceding paper were first read at the opening of our new
Institute on March 16, 1953. Simultaneously, nearly identical observations and
conclusions were in press in the important book 'Aetiologie und Prophylaxe des
Lungenkrebses ' by F. Lickint (Dresden-Leipzig, 1953), unknown to the present
author until our two papers were in press.
This study has been aided by a generous grant from "Tobaksfabrikernes
Landsforening av 1901."
I am likewise greatly indepted to Dr. Knut Westlund for very valuable
assistance during the preparation of the manuscript.
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